Beam Therapeutics Files Lawsuit Against Chinese Biotech Startup Over Alleged IP Theft

Beam Therapeutics claims that one of its scientists misappropriated proprietary gene-editing technology to establish a Chinese biotech company, which has subsequently secured venture capital investment.